PES CON 2019 vs LabPad+
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
PES CON 2019
Read full descriptionHide full description
Pakistan Endocrine Society has come a long way, from a handful of endocrinologists to over seventy formally qualified and trained endocrinologists as active executive members.
LabPad+
Read full descriptionHide full description
Intended to be used by healthcare professionals, LabPad+ is a smartphone/tablet application that connects via Bluetooth to AVALUN’s LabPad devices(1). Once connected, LabPad+ allows to perform a biological test by associating to the result all the useful traceability information concerning the test performed, the operator, the patient and any contextual comments. To download the user manual of LabPad+ click here: https://avalun.com/wp-content/uploads/2021/04/LabPad-user-manual-EN.pdf (1) LabPad devices are CE marked Point-Of-Care (POC) In Vitro Diagnostic Medical Devices manufactured by AVALUN which are authorized for use in European Community (EC) countries and in countries that recognize the CE mark.
Screenshots
Verdict
The clearest difference is iOS requirement: PES CON 2019 at 9.0 against LabPad+'s 12.0. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | PES CON 2019 | LabPad+ |
|---|---|---|
| Price | Free | Free |
| Update frequency | — | Every 4 months |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 9.0 — better | 12.0 |
| Further details — not scored | ||
| Size | 34 MB | 36 MB |
| Age rating | 4+ | 4+ |
| Developer | PHARMEVO PRIVATE LIMITED | BIOSYNEX |
In-app purchases
PES CON 2019
No in-app purchases
LabPad+
No in-app purchases
